Loading…
LFWD
Lifeward Ltd.
NASDAQ· Healthcare· Medical Devices· CUSIP M8216Q309
$7.46+1.29%Price as of Aug 29, 18:44 UTC · updated once a day, after the close
Key metrics
- Market cap
- $21.13M
- P/E
- —
- Forward P/E
- —
- P/B
- 3.3x
- Dividend yield
- —
- Payout
- —
- EPS
- -$14.85
- ROE
- -225.65%
- Profit margin
- -141.28%
- Revenue growth
- +15.70%
- Beta
- 0.39
- 52-week high
- $10.56
- 52-week low
- $4.14
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -93.5% over 5Y.
today you would have $55.11▼ -94.5%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $6.92 | $20.76 | $65.35 | $63.84 | |
| P/S | 2.0x | 0.5x | 0.6x | 3.4x | 8.3x |
| P/B | 0.9x | 1.3x | 0.8x | 1.0x | 0.7x |
| EPS | -$17.16 | -$39.96 | -$31.13 | -$26.35 | |
| Profit margin | -136.27% | -90.38% |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| CTSOCytosorbents Corp | $0.34 | — | — | — | -336.21% | $21.09M |
| COCPCocrystal Pharma, Inc. | $1.10 | — | 14.5x | — | -311.68% | $21.19M |
| LGVNLongeveron Inc. | $6.72 | — | 20.5x | — | -203.61% | $21.42M |
| AKTXAkari Therapeutics Plc | $10.70 |
About the company
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.
- 81
- Yokneam Illit, Israel
Company description provided by Yahoo Finance.